- ￥4800
- Tanda
- 美国
- TD-26077
- 2025年10月29日
- ELISA, WB, IF, IHC
- Mouse
- 脊椎动物
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
A synthetic peptide from the internal region of EGFR which includes the mutation of L861Q, human origin.
- 亚型：
lgG
- 形态：
液体
- 保存条件：
-20℃
- 克隆性：
单克隆
- 标记物：
FITC
- 适应物种：
脊椎动物
- 保质期：
24个月
- 抗原来源：
蛋白
- 目录编号：
TD-26077
- 级别：
科研级
- 库存：
999
- 供应商：
武汉天德
- 宿主：
Mouse
- 应用范围：
ELISA, WB, IF, IHC
- 浓度：
1mg/ml
- 靶点：
L861Q
- 抗体英文名：
Anti EGFR(L861Q) Mouse Monoclonal Antibody
- 抗体名：
EGFR(L861Q)
- 规格：
100 μL
EGFR(L861Q)
| Cat. #: TD-26077 |
| Gene Symbol: EGFR/HER1/ERBB1 |
| Description: Anti-EGFR(L861Q) Mouse Monoclonal Antibody |
| Background: EGFR is a receptor tyrosine kinase binding ligands of the EGF family and activating several signaling cascades to convert extracellular cues into appropriate cellular responses. It activates at least 4 major downstream signaling cascades including the RAS-RAF-MEK-ERK, PI3 kinase-AKT, PLC gamma-PKC and STATs modules. Defects in EGFR are associated with lung cancer (LNCR). |
| Immunogen: A synthetic peptide from the internal region of EGFR which includes the mutation of L861Q, human origin. |
| Tested Applications: ELISA, WB, IF, IHC |
| Recommended Dilutions: ELISA: 1:1000-1:5000 WB: 1:1000-1:5000 IHC: 1:50-1:200 |
| Concentration: 1 mg/ml |
| Host Species: Mouse |
| Format: Liquid |
| Clonality: Monoclonal |
| Isotype: |
| Purity: Purified from ascites |
| Preservative: No |
| Constituents: PBS (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 50% glycerol |
| Species Reactivity: Recognizes EGFR(L861Q), but not wild type EGFR from vertebrates. |
| Storage Conditions: Store at -20°C. Avoid repeated freezing and thawing. |
| Western blot:
Immunofluorescence of cells expressing EGFR proteins with anti-EGFR(L861Q) antibody. HEK293T cells were transfected with pCDNA3-GFP-EGFR (WT) plasmid (left column) or pCDNA3-GFP-EGFR(L861Q) plasmid (right column), then fixed and stained with anti- EGFR(L861Q) monoclonal antibody (Cat. #TD-26077). |
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验厦门大学的研究团队评估了 EGFR 作为三阴乳腺癌免疫治疗靶点的可能性，通过体内实验和体外实验的结果得出，EGFR CAR-T 细胞展示出对三阴乳腺癌细胞强大的杀伤效果和潜力，提出 EGFR CAR-T 可以进一步向临床方向进行探索，获益更多的患者。 三阴乳腺癌（TNBC）以其侵袭性强、复发快速和预后效果差而闻名。目前以嵌合抗原受体 T (CAR-T)细胞为首的免疫疗法，已经成为治疗 TNBC 的一种有效工具，而其中肿瘤特异性抗原的选择和 CAR 结构的设计成为 CAR-T 治疗的挑战。 中国
Clinical Advancement of EGFR Inhibitors in Cancer Therapy
The epidermal growth factor receptor (EGFR) represents one of the most promising molecular targets in cancer therapeutics. An array of EGFR inhibitory drugs have been developed that are progressing rapidly in oncology clinical trials
Phosphotyrosine Kinase Assays as a Prescreen for Inhibitors of EGFr
The epidermal growth factor receptor (EGFr) is a 170-kDa glycosylated transmembrane protein found in a wide variety of tissues (1 ). It is the receptor for epidermal growth factor (EGF), transforming growth factor α (TGFα), and other related
技术资料暂无技术资料 索取技术资料
